Evidence map›Paper›PMID 32537281›Full record

ArticleCureus2020

Solitary, Late Metastatic Recurrence of Renal Cell Carcinoma to the Pancreas: A Case Report.

Khalil Choucair, Nathaniel A Parker, Ammar Al-Obaidi, Joel Alderson, Phu Truong

Abstract readCase Reports
In one paragraph

Article in Cureus, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Khalil ChoucairInternal Medicine, University of Kansas School of Medicine, Wichita, USA.
Nathaniel A ParkerInternal Medicine, University of Kansas School of Medicine, Wichita, USA.
Ammar Al-ObaidiInternal Medicine, University of Kansas School of Medicine, Wichita, USA.
Joel AldersonPathology, Ascension Via Christi St. Francis Hospital, Wichita, USA.
Phu TruongHematology/Oncology, Cancer Center of Kansas, Wichita, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Renal cell carcinoma (RCC) accounts for 3% of all adult malignancies and is known for metastatic initial presentation, unpredictable metastatic pathway, and late recurrence post-curative resection. We report a case of solitary late metastatic renal cell carcinoma to the pancreas more than 10 years after radical nephrectomy. A high index of suspicion must be maintained to detect RCC late recurrence and metastasis to rare and atypical locations. A lifelong follow-up is recommended.

Indexed as

carcinomaclear renal cell carcinomalate recurrencemetastasispancreatic metastasisrenal cell

Identifiers

PMID32537281
PMCPMC7286586

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.